1. Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial. Issue 3 (March 2022) Authors: Temesgen, Zelalem; Burger, Charles D; Baker, Jason; Polk, Christopher; Libertin, Claudia R; Kelley, Colleen F; Marconi, Vincent C; Orenstein, Robert; Catterson, Victoria M; Aronstein, William S; Durrant, Cameron; Chappell, Dale; Ahmed, Omar; Chappell, Gabrielle; Badley, Andrew D; Lewis, Meghan; S... Journal: Lancet Issue: Volume 10:Issue 3(2022) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lipidome Profiling of APOE4 AD brains implicated unresolved neuroinflammation involving polyunsaturated fatty acid metabolism. (20th December 2022) Authors: Asante, Isaac; Ebright, Brandon; Wang, Shaowei; Poblete, Roy; Arvanitakis, Zoe; Bennett, David A; Louie, Stan G; Yassine, Hussein N. Journal: Alzheimer's & dementia Issue: Volume 18(2022)Supplement 4 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗